Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T06273 | Target Info | |||
Target Name | Poly [ADP-ribose] polymerase 1 (PARP1) | ||||
Synonyms | Protein poly-ADP-ribosyltransferase PARP1; Poly[ADP-ribose] synthetase-1; Poly[ADP-ribose] synthase 1; Poly(ADP-ribose)polymerase-1; PPOL; PARP-1; NAD(+)Poly [ADP-ribose] polymerase-1 ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase 1; DNA ADP-ribosyltransferase PARP1; ARTD1; ADPRT 1; ADPRT; ADP-ribosyltransferase diphtheria toxin-like 1 | ||||
Target Type | Successful Target | ||||
Gene Name | PARP1 | ||||
Biochemical Class | Glycosyltransferases | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 2 Acid anhydride hydrolases | + | |||
Interacting Target Name | X-ray repair cross-complementing 5 (Ku80) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | X-ray repair cross-complementing protein 5; X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining); TLAA; Thyroid-lupus autoantigen; Nuclear factor IV; Lupus Ku autoantigen protein p86; Ku86; G22P2; DNA repair protein XRCC5; CTCBF; CTC85; CTC box-binding factor 85 kDa subunit; ATP-dependent DNA helicase II 80 kDa subunit; ATP-dependent DNA helicase 2 subunit 2; 86 kDa subunit of Ku antigen | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Biochemical Activity | [5] | |||
6 | Reconstituted Complex | [4] | |||
7 | Reconstituted Complex | [5] | |||
8 | Reconstituted Complex | [6] | |||
Interacting Protein Name | X-ray repair cross-complementing protein 6 (XRCC6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CTC75; CTCBF; G22P1; KU70; ML8; TLAA | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Biochemical Activity | [5] | |||
6 | Reconstituted Complex | [4] | |||
7 | Reconstituted Complex | [5] | |||
8 | Reconstituted Complex | [6] | |||
Acyltransferases | [+] 2 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Affinity Capture-Western | [9] | |||
4 | Affinity Capture-Western | [10] | |||
5 | Reconstituted Complex | [8] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase CHFR (CHFR) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF116; RNF196 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Affinity Capture-Western | [12] | |||
3 | Biochemical Activity | [13] | |||
Carbon-nitrogen hydrolases | [+] 1 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Biochemical Activity | [15] | |||
Histones | [+] 1 Histones | + | |||
Interacting Target Name | Gamma-Histone H2AX (H2AFX) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Phosphorylation of H2AX; Histone H2AX; Histone H2A.x; H2AX; H2a/x | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [16] | |||
2 | Affinity Capture-Western | [16] | |||
3 | Reconstituted Complex | [17] | |||
Isomerases | [+] 1 Isomerases | + | |||
Interacting Target Name | DNA topoisomerase I (TOP1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DNA topoisomerase I | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [18] | |||
2 | Affinity Capture-Western | [19] | |||
3 | Co-fractionation | [19] | |||
4 | Fluorescence Resonance Energy Transfer | [19] | |||
5 | Reconstituted Complex | [19] | |||
Kinases | [+] 3 Kinases | + | |||
Interacting Protein Name | DNA polymerase beta (POLB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [20] | |||
2 | Affinity Capture-Western | [21] | |||
3 | Reconstituted Complex | [20] | |||
Interacting Target Name | Cyclin-dependent kinase 8 (CDK8) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein kinase K35; Mediator of RNA polymerase II transcription subunit CDK8; Mediator complex subunit CDK8; Cell division protein kinase 8 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Reconstituted Complex | [8] | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 1 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [23] | |||
Lyases | [+] 1 Lyases | + | |||
Interacting Protein Name | Aprataxin and PNK-like factor (APLF) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | APFL; C2orf13; PALF; Xip1; ZCCHH1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [13] | |||
2 | Reconstituted Complex | [24] | |||
Mediator complexes | [+] 1 Mediator complexes | + | |||
Interacting Protein Name | Mediator of RNA polymerase II transcription subunit 6 (MED6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ARC33; NY.REN.28 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Reconstituted Complex | [22] | |||
Nuclear hormone receptors | [+] 1 Nuclear hormone receptors | + | |||
Interacting Target Name | Estrogen receptor (ESR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oestrogen receptor alpha; Oestrogen receptor; Nuclear receptor subfamily 3 group A member 1; NR3A1; Estrogen receptor alpha; Estradiol receptor; ESR; ER-alpha; ERalpha; ER | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [25] | |||
2 | Affinity Capture-Western | [2] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [26] | |||
2 | Reconstituted Complex | [27] | |||
3 | Reconstituted Complex | [28] | |||
Transcription regulators | [+] 3 Transcription regulators | + | |||
Interacting Protein Name | Transcription factor p65 (RELA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NFKB3; p65 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Reconstituted Complex | [29] | |||
3 | Reconstituted Complex | [8] | |||
Interacting Target Name | DNA-binding factor KBF1 (p105) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; Nuclear factor of kappa light polypeptide gene enhancer in Bcells 1; Nuclear factor NFkappaB p50 subunit; Nuclear factor NF-kappa-B p105 subunit; Nuclear factor NFkappaB p105 subunit; EBP-1; EBP1; DNA-binding factor KBF1; DNAbinding factor KBF1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Reconstituted Complex | [8] | |||
Interacting Target Name | Transcription factor 7-like 2 (TCF7L2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TCF-4; TCF4; T-cell-specific transcription factor 4; T-cell transcription factor-4; T-cell factor 4; HTCF-4; HMG box transcription factor 4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [31] | |||
2 | Affinity Capture-Western | [3] | |||
Other proteins | [+] 3 Other proteins | + | |||
Interacting Target Name | Proliferating cell nuclear antigen (PCNA) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclin | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [20] | |||
2 | Affinity Capture-Western | [32] | |||
3 | Affinity Capture-Western | [21] | |||
4 | Reconstituted Complex | [20] | |||
Interacting Target Name | Melanoma differentiation-associated protein 6 (CDKN1A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WAF1; SDI1; PIC1; P21(WAF1); P21; Melanoma differentiation associated protein 6; MDA-6; MDA6; Cyclin-dependent kinase inhibitor 1; CIP1; CDK-interacting protein 1; CAP20 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [20] | |||
2 | Affinity Capture-Western | [21] | |||
3 | Reconstituted Complex | [20] | |||
Interacting Target Name | Beta-catenin (CTNNB1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Wnt/beta-catenin signaling pathway; PRO2286; OK/SW-cl.35; CTNNB; Catenin beta-1 | ||||
Evidence Score (E-score) | 1 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [33] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription. Free Radic Biol Med. 2014 Feb;67:69-80. | ||||
REF 2 | A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science. 2006 Jun 23;312(5781):1798-802. | ||||
REF 3 | Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling. Cancer Res. 2007 Feb 1;67(3):911-8. | ||||
REF 4 | Poly(ADP-ribose) polymerase and Ku autoantigen form a complex and synergistically bind to matrix attachment sequences. J Biol Chem. 1999 Jul 16;274(29):20521-8. | ||||
REF 5 | Identification and biochemical characterization of a Werner's syndrome protein complex with Ku70/80 and poly(ADP-ribose) polymerase-1. J Biol Chem. 2004 Apr 2;279(14):13659-67. | ||||
REF 6 | In prostate cancer cells the interaction of C/EBPalpha with Ku70, Ku80, and poly(ADP-ribose) polymerase-1 increases sensitivity to DNA damage. J Biol Chem. 2006 Apr 28;281(17):11496-505. | ||||
REF 7 | Protein arginine methyltransferase 1 coactivates NF-kappaB-dependent gene expression synergistically with CARM1 and PARP1. J Mol Biol. 2008 Mar 28;377(3):668-78. | ||||
REF 8 | Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem. 2005 Dec 9;280(49):40450-64. | ||||
REF 9 | p300 cooperates with c-Jun and PARP-1 at the p300 binding site to activate RhoB transcription in NSC126188-mediated apoptosis. Biochim Biophys Acta. 2014 May;1839(5):364-73. | ||||
REF 10 | Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem. 2003 Nov 14;278(46):45145-53. | ||||
REF 11 | CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation. J Biol Chem. 2012 Apr 13;287(16):12975-84. | ||||
REF 12 | Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer. Oncotarget. 2015 Oct 13;6(31):30773-86. | ||||
REF 13 | Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins. Nature. 2008 Jan 3;451(7174):81-5. | ||||
REF 14 | Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature. 2010 Jul 1;466(7302):62-7. | ||||
REF 15 | SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Mol Cell Biol. 2009 Aug;29(15):4116-29. | ||||
REF 16 | The dynamic alterations of H2AX complex during DNA repair detected by a proteomic approach reveal the critical roles of Ca(2+)/calmodulin in the ionizing radiation-induced cell cycle arrest. Mol Cell Proteomics. 2006 Jun;5(6):1033-44. | ||||
REF 17 | FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16. Mol Cell. 2008 Apr 11;30(1):86-97. | ||||
REF 18 | Proteomic analysis of complexes formed by human topoisomerase I. Biochim Biophys Acta. 2005 May 20;1749(1):133-41. | ||||
REF 19 | Poly(ADP-ribosyl)ation as a DNA damage-induced post-translational modification regulating poly(ADP-ribose) polymerase-1-topoisomerase I interaction. J Biol Chem. 2004 Sep 17;279(38):39686-96. | ||||
REF 20 | p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1. DNA Repair (Amst). 2010 Jun 4;9(6):627-35. | ||||
REF 21 | Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer. Mol Cancer. 2010 Mar 19;9:64. | ||||
REF 22 | PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol Cell. 2005 Apr 1;18(1):83-96. | ||||
REF 23 | Importance of EGFR/ERCC1 interaction following radiation-induced DNA damage. Clin Cancer Res. 2014 Jul 1;20(13):3496-506. | ||||
REF 24 | A novel human AP endonuclease with conserved zinc-finger-like motifs involved in DNA strand break responses. EMBO J. 2007 Apr 18;26(8):2094-103. | ||||
REF 25 | Identification of proteins associated with ligand-activated estrogen receptor in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS. Proteomics. 2011 Jan;11(1):172-9. | ||||
REF 26 | Aprataxin, a novel protein that protects against genotoxic stress. Hum Mol Genet. 2004 May 15;13(10):1081-93. | ||||
REF 27 | Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1. J Cell Biochem. 2003 Aug 15;89(6):1260-84. | ||||
REF 28 | PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase. Oncogene. 2003 Nov 20;22(52):8460-71. | ||||
REF 29 | The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J Biol Chem. 2001 Dec 7;276(49):45588-97. | ||||
REF 30 | Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1. Oncogene. 2006 Dec 14;25(59):7714-22. | ||||
REF 31 | Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in -Catenin-Active Cancers. Cell Syst. 2016 Sep 28;3(3):302-316.e4. | ||||
REF 32 | Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners. J Biol Chem. 2003 Oct 10;278(41):39265-8. | ||||
REF 33 | Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology. 2005 Oct;129(4):1225-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.